Gerresheimer AG
GRRMFOTCHealthcare● Active
$32.20
+$0.10(+0.31%)
Market Cap$1.1B
P/E Ratio—
52W High$73.8
52W Low$19.165
Gerresheimer AG (GRRMF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GRRMF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 16, 2026EPS Actual
$0.38
Est. $0.38 · +0.0%
Revenue
$0.61B
Est. $0.61B · +0.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 16, 2026
After Market Close
✓ 2-Quarter EPS Beat Streak
GRRMF reports quarterly as a OTC-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 10, 2026 | $0.76 | — | — | — | $0.71B | — |
| — Q2 FY2026 | Apr 16, 2026 | $0.38 | $0.38 | +0.0% | $0.61B | $0.61B | +0.0% |
| ◌ Q1 FY2026 | Mar 31, 2026 | $0.38 | — | — | — | $0.71B | — |
| — Q1 FY2026 | Feb 25, 2026 | -$0.07 | -$0.07 | +0.0% | $0.70B | $0.71B | -1.1% |
| ▼ Q3 FY2025 | Jul 10, 2025 | $0.92 | $0.56 | -38.9% | $0.68B | $0.70B | -2.6% |
| — Q4 FY2024 | Nov 30, 2024 | — | $1.14 | — | $0.60B | — | — |
| ▼ Q4 FY2024 | Oct 10, 2024 | $1.18 | $1.15 | -2.5% | $0.55B | $0.61B | -10.3% |
| — Q3 FY2024 | Jul 11, 2024 | $1.24 | $1.24 | +0.0% | $0.54B | $0.56B | -2.5% |
Q2 FY2026
Jun 10, 2026
EPS Actual
—
EPS Est.
$0.76
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 16, 2026
EPS Actual
$0.38
EPS Est.
$0.38
EPS Surpr.
+0.0%
Revenue
$0.61B
Q1 FY2026
Mar 31, 2026
EPS Actual
—
EPS Est.
$0.38
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 25, 2026
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
+0.0%
Revenue
$0.70B
Q3 FY2025
Jul 10, 2025Miss
EPS Actual
$0.56
EPS Est.
$0.92
EPS Surpr.
-38.9%
Revenue
$0.68B
Q4 FY2024
Nov 30, 2024
EPS Actual
$1.14
EPS Est.
—
EPS Surpr.
—
Revenue
$0.60B
Q4 FY2024
Oct 10, 2024Miss
EPS Actual
$1.15
EPS Est.
$1.18
EPS Surpr.
-2.5%
Revenue
$0.55B
Q3 FY2024
Jul 11, 2024
EPS Actual
$1.24
EPS Est.
$1.24
EPS Surpr.
+0.0%
Revenue
$0.54B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.37 | $0.37 | $0.37 | 1 |
| Q3 FY2026 | $0.69 | $0.69 | $0.69 | 1 |
| Q2 FY2026 | $0.65 | $0.65 | $0.65 | 1 |
| Q1 FY2026 | $0.32 | $0.32 | $0.32 | 1 |
| Q4 FY2025 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Q3 FY2025 | $0.81 | $0.81 | $0.82 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.6B | $0.6B | $0.6B | 1 |
| Q3 FY2026 | $0.6B | $0.6B | $0.6B | 1 |
| Q2 FY2026 | $0.6B | $0.6B | $0.6B | 1 |
| Q1 FY2026 | $0.5B | $0.5B | $0.5B | 1 |
| Q4 FY2025 | $0.6B | $0.6B | $0.6B | 2 |
| Q3 FY2025 | $0.6B | $0.6B | $0.6B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 16, 2026 | +0.0% | $20.65 | $20.65 | +0.00% |
| ▲ Q1 FY2026 | Feb 25, 2026 | +0.0% | $51.41 | $20.03 | -61.04% |
| ▼ Q3 FY2025 | Jul 10, 2025 | -38.9% | $53.55 | $53.55 | +0.00% |
| — Q4 FY2024 | Nov 30, 2024 | — | $90.30 | $78.35 | -13.23% |
| ▼ Q4 FY2024 | Oct 10, 2024 | -2.5% | $85.00 | $90.30 | +6.24% |
| ▲ Q3 FY2024 | Jul 11, 2024 | +0.0% | $106.12 | $109.84 | +3.51% |
| ▲ Q2 FY2024 | Apr 11, 2024 | +1.6% | $113.05 | $109.34 | -3.28% |
| — Q4 FY2023 | Nov 30, 2023 | — | No price data | $102.60 | — |
Q2 FY2026+0.00%
Report Date
Apr 16, 2026
EPS Beat/Miss
+0.0%
Price Before
$20.65
Price After
$20.65
Q1 FY2026-61.04%
Report Date
Feb 25, 2026
EPS Beat/Miss
+0.0%
Price Before
$51.41
Price After
$20.03
Q3 FY2025+0.00%
Report Date
Jul 10, 2025
EPS Beat/Miss
-38.9%
Price Before
$53.55
Price After
$53.55
Q4 FY2024-13.23%
Report Date
Nov 30, 2024
EPS Beat/Miss
—
Price Before
$90.30
Price After
$78.35
Q4 FY2024+6.24%
Report Date
Oct 10, 2024
EPS Beat/Miss
-2.5%
Price Before
$85.00
Price After
$90.30
Q3 FY2024+3.51%
Report Date
Jul 11, 2024
EPS Beat/Miss
+0.0%
Price Before
$106.12
Price After
$109.84
Q2 FY2024-3.28%
Report Date
Apr 11, 2024
EPS Beat/Miss
+1.6%
Price Before
$113.05
Price After
$109.34
Q4 FY2023—
Report Date
Nov 30, 2023
EPS Beat/Miss
—
Price Before
—
Price After
$102.60
Avg Beat Reaction-15.20%
Avg Miss Reaction+3.12%
Beat Rate4 / 8 quarters
Largest Move-61.04% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GRRMF ends December
Gerresheimer AG (GRRMF) most recently reported earnings on April 16, 2026 for Q2 FY2026, posting EPS of $0.38 (in line with the analyst consensus of $0.38). GRRMF has beaten EPS estimates for 2 consecutive quarters. The next GRRMF earnings date is expected around September 1, 2026.
Each quarter, investors track GRRMF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GRRMF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GRRMF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GRRMF earnings · 4 questionsGerresheimer AG's next earnings report is expected around September 1, 2026. GRRMF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GRRMF historically reports after market close (AMC).
GRRMF earnings datewhen is GRRMF earningsGRRMF next earnings datewhen does GRRMF report earningsGRRMF earnings calendar
▸ Source: FMP · Gerresheimer AG SEC filings · US GAAP · Gerresheimer AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026